Literature DB >> 30003527

Emergence of co-existence of blaNDM with rmtC and qnrB genes in clinical carbapenem-resistant Klebsiella pneumoniae isolates in burning center from southeast of Iran.

Somayeh Kiaei1,2, Mohammad Moradi1, Hossein Hosseini Nave1, Zahra Hashemizadeh2, Majid Taati-Moghadam2, Davood Kalantar-Neyestanaki3.   

Abstract

Dissemination of carbapenemase-producing Klebsiella pneumoniae along with 16S rRNA methyltransferase (16S-RMTase) has been caused as a great concern for healthcare settings. The aim of this study was to investigate the prevalence of resistance genes among K. pneumoniae isolates. During October 2015 to February 2016, 30 non-duplicative K. pneumoniae strains were isolated from clinical specimens in a burn center in Kerman, Iran. Antibiotic susceptibility tests of isolates, carbapenemase, extended-spectrum beta-lactamases (ESBLs) and AmpC beta-lactamase-producing isolates were determined by phenotypic methods. The beta-lactamase, oqxA/B efflux pumps, qnr A, B, S, 16S-RMTase (rmt A, B, and C), and mcr-1 resistance genes were determined by PCR. Enterobacterial repetitive intergenic consensus (ERIC)-PCR was used for molecular typing. According to our findings, tigecycline has been shown the most active agent against K. pneumoniae isolates. Antibiotic resistance genes, blaTEM-1, blaSHV-12, blaCTX-M-15, blaCTX-M-2, blaNDM-1, blaFOX, blaMOX, blaEBC, blaACC, blaCIT, rmtC, qnrB, qnrS, oqxA, and oqxB, were detected in 11 (36.7%), 13 (43.3%), 11 (36.6%), 5 (16.6%), 9 (30%), 1 (3.3%), 1 (3.3%), 1 (3.3%), 1 (3.3%), 2 (6.7%), 1 (3.3%), 9 (30%), 2 (6.7%), 18 (60%), and 13 (43.3%) of isolates, respectively. The blaNDM-1 with rmtC was simultaneously observed in one isolate. ERIC-PCR results revealed 25 distinct patterns in eight clusters (A-H) and five singletons. This study highlights the high prevalence of blaNDM and emergence of rmtC among carbapenem-resistant K. pneumoniae. The resistance genes are often co-located on the conjugative plasmids, so it might be the reason of the rapid spread of them. The prevalence of multidrug-resistant K. pneumoniae isolates limits the available treatment options and presents tremendous challenges to public health.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30003527     DOI: 10.1007/s12223-018-0630-3

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  41 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 2.  The emerging NDM carbapenemases.

Authors:  Patrice Nordmann; Laurent Poirel; Timothy R Walsh; David M Livermore
Journal:  Trends Microbiol       Date:  2011-11-09       Impact factor: 17.079

3.  Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae.

Authors:  H-J Monstein; A Ostholm-Balkhed; M V Nilsson; M Nilsson; K Dornbusch; L E Nilsson
Journal:  APMIS       Date:  2007-12       Impact factor: 3.205

4.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

Review 5.  Combinatorial events of insertion sequences and ICE in Gram-negative bacteria.

Authors:  Mark A Toleman; Timothy R Walsh
Journal:  FEMS Microbiol Rev       Date:  2011-07-29       Impact factor: 16.408

6.  qnr, aac(6')-Ib-cr and qepA genes in Escherichia coli and Klebsiella spp.: genetic environments and plasmid and chromosomal location.

Authors:  Elena Ruiz; Yolanda Sáenz; Myriam Zarazaga; Rosa Rocha-Gracia; Luis Martínez-Martínez; Guillaume Arlet; Carmen Torres
Journal:  J Antimicrob Chemother       Date:  2012-01-04       Impact factor: 5.790

7.  Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in Enterobacteriaceae isolated in India and the UK.

Authors:  Laura Hidalgo; Katie L Hopkins; Belen Gutierrez; Cristina M Ovejero; Suruchi Shukla; Stephen Douthwaite; Kashi N Prasad; Neil Woodford; Bruno Gonzalez-Zorn
Journal:  J Antimicrob Chemother       Date:  2013-04-11       Impact factor: 5.790

Review 8.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

Authors:  L Silvia Munoz-Price; Laurent Poirel; Robert A Bonomo; Mitchell J Schwaber; George L Daikos; Martin Cormican; Giuseppe Cornaglia; Javier Garau; Marek Gniadkowski; Mary K Hayden; Karthikeyan Kumarasamy; David M Livermore; Juan J Maya; Patrice Nordmann; Jean B Patel; David L Paterson; Johann Pitout; Maria Virginia Villegas; Hui Wang; Neil Woodford; John P Quinn
Journal:  Lancet Infect Dis       Date:  2013-09       Impact factor: 25.071

9.  Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria.

Authors:  Lars Hestbjerg Hansen; Lars Bogø Jensen; Heidi Iskou Sørensen; Søren Johannes Sørensen
Journal:  J Antimicrob Chemother       Date:  2007-05-24       Impact factor: 5.790

10.  Phenotypic and molecular characterization of plasmid mediated AmpC β-lactamases among Escherichia coli, Klebsiella spp., and Proteus mirabilis isolated from urinary tract infections in Egyptian hospitals.

Authors:  Mai M Helmy; Reham Wasfi
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411

View more
  7 in total

Review 1.  Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria.

Authors:  Majid Taati Moghadam; Ali Mojtahedi; Mehrdad Moosazadeh Moghaddam; Mahdi Fasihi-Ramandi; Reza Mirnejad
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-23       Impact factor: 5.560

2.  The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa.

Authors:  Mahsa Shahbandeh; Majid Taati Moghadam; Reza Mirnejad; Shiva Mirkalantari; Mehrnaz Mirzaei
Journal:  Int J Nanomedicine       Date:  2020-09-21

Review 3.  Bacteriophage as a Novel Therapeutic Weapon for Killing Colistin-Resistant Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Bacteria.

Authors:  Seyed Mohammad Mousavi; Sajad Babakhani; Leila Moradi; Saina Karami; Mahsa Shahbandeh; Maryam Mirshekar; Samane Mohebi; Majid Taati Moghadam
Journal:  Curr Microbiol       Date:  2021-10-11       Impact factor: 2.343

4.  Intestinal Colonization with Carbapenem-Resistant Enterobacteriaceae in Acute Leukemia Patients: Risk Factors and Molecular Characteristics.

Authors:  Rongping Zhu; Xiaohong Xu; Siyan Lian; Meili Cai; Hui Zhang; Xin Chen; Yingping Cao
Journal:  Infect Drug Resist       Date:  2022-08-06       Impact factor: 4.177

Review 5.  Research Updates of Plasmid-Mediated Aminoglycoside Resistance 16S rRNA Methyltransferase.

Authors:  Weiwei Yang; Fupin Hu
Journal:  Antibiotics (Basel)       Date:  2022-07-07

6.  Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection.

Authors:  Qun Lin; Yue Wang; Jing Yu; Shusheng Li; Yicheng Zhang; Hui Wang; Xiaoquan Lai; Dong Liu; Liyan Mao; Ying Luo; Guoxing Tang; Zhongju Chen; Ziyong Sun
Journal:  BMC Infect Dis       Date:  2021-07-02       Impact factor: 3.090

Review 7.  Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach.

Authors:  Iman Dandachi; Amer Chaddad; Jason Hanna; Jessika Matta; Ziad Daoud
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.